| MRNA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the Moderna market cap history going back to 12/7/2018:
Also see: MRNA Shares Outstanding History and MRNA YTD Return |
Moderna Market Cap History — Moderna Capitalization Over Time
As of 7/24/2026 Moderna has a market cap of 21.59 billion. Investors often follow the MRNA market cap history to compare the size of the company over time.
This page shows MRNA market capitalization trends over time, with 32 market cap datapoints presented, dating back to 12/7/2018.
| MRNA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Moderna Historical Market Cap: +18.18% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MRNA Stock Price Chart |
| About Moderna Inc |
| Moderna, Inc. is a biotechnology company. Co. is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. We show 32 historical shares outstanding datapoints in our MRNA shares outstanding history coverage, used to compute MRNA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing Moderna market cap history over the course of time is important for investors interested in comparing Moderna's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of Moderna versus a peer is one thing; comparing Moderna market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like Moderna can fluctuate over the course of history. With this page we aim to empower investors researching Moderna by allowing them to research the Moderna market cap history. |
| MRNA Current Stock Quote |
Quotes delayed 20 minutes  Free MRNA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| MRNA Share Performance |
| Market Cap Peers |
| Moderna (MRNA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MRNS Market Cap History MRSN Market Cap History MRTX Market Cap History MRVI Market Cap History MSON Market Cap History MTCR Market Cap History MTEM Market Cap History MTVA Market Cap History MXCT Market Cap History MYGN Market Cap History More Healthcare companies » |
Moderna Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
